Analysis of Ligustrazine and Xuesaitong in the Treatment of Cerebral Infarction Clinical Comparison

Objective To investigate the injection and Xuesetong different clinical effects of the two drugs for the treatment of cerebral infarction, parallel to the contrast. Methods Patients with acute cerebral infarction choose to take my brain hospital since July 2013 to June 2014 by a total of 40 cases were treated, according to the different treatment groups as follows: the reference group 20 cases, patients injected three courses of TMP injection, treatment group 20 cases, patients injected three courses of Xuesetong injection. the changes compared two groups of patients with clinical efficacy. Results The total efficiency of the treatment group was 95.00%, the total efficiency of the reference group was 70.00%, and the total treatment group was far more efficient than the reference group was 25.00%, compared to the effect significantly(P0.05), the difference was statistically significant. Conclusion For clinical treatment of acute cerebral infarction, Xuesetong TMP has a more than significant results..